Acs Fall 2024 Vvd-130037 Vvd130037c. Trial participants will have a histologically confirmed metastatic or unresectable solid tumor. Choose from thousands of presentations, network, attend courses and visit the expo.
Vividion has already disclosed work on covalent keap1 inhibitors, but at the recent acs fall 2024 meeting, the structure and discovery story of their clinical oral. Choose from thousands of presentations, network, attend courses and visit the expo.
Acs Fall 2024 Vvd-130037 Vvd130037c Images References :